The complexities of integrating processes and scaling-up the manufacturing of cell and gene therapies is a topic that is prevalent in our maturing industry. Vendors and producers are focusing heavilyon developing purpose-built solutions, integrating as many steps as possible, sometimes leveraging entirely new technologies rather than legacy approaches from the blood processing and biologics sector. This can present new challenges as the implementation often impacts process development, automation and regulatory teams within an organization.
This webinar provide a short example of the ekko™ system processing cell aggregates while integrated with a bioreactor. A cross-functional panel discuss integration challenges and learnings related to an integration strategy.